These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25466634)

  • 1. Divergent effects of type-I interferons on regulatory T cells.
    Piconese S; Pacella I; Timperi E; Barnaba V
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):133-41. PubMed ID: 25466634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation.
    Utsumi M; Takaki A; Umeda Y; Koike K; Napier SC; Watanabe N; Sadamori H; Shinoura S; Yoshida R; Nobuoka D; Yasunaka T; Nakayama E; Yamamoto K; Fujiwara T; Yagi T
    Transpl Immunol; 2014 Jun; 31(1):33-41. PubMed ID: 24907425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients.
    Pentón-Rol G; Cervantes-Llanos M; Cabrera-Gómez JA; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Lara R; Montero-Casimiro E; Bello-Rivero I; López-Saura P
    Int Immunopharmacol; 2008 Jun; 8(6):881-6. PubMed ID: 18442793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus.
    La Rocca C; Carbone F; Longobardi S; Matarese G
    Immunol Lett; 2014 Nov; 162(1 Pt A):41-8. PubMed ID: 24996040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
    Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
    Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis.
    Haas J; Korporal M; Balint B; Fritzsching B; Schwarz A; Wildemann B
    J Neuroimmunol; 2009 Nov; 216(1-2):113-7. PubMed ID: 19646767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of regulatory T-cell lineage.
    Hori S
    Adv Immunol; 2011; 112():1-24. PubMed ID: 22118405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells.
    Cong Y; Wang L; Konrad A; Schoeb T; Elson CO
    Eur J Immunol; 2009 Nov; 39(11):3134-46. PubMed ID: 19839007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
    Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
    J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring the frequency and function of regulatory T cells and summary of the approaches currently used to inhibit regulatory T cells in cancer patients.
    Camisaschi C; Tazzari M; Rivoltini L; Castelli C
    Methods Mol Biol; 2014; 1139():201-21. PubMed ID: 24619682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
    Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
    J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C.
    Akiyama M; Ichikawa T; Miyaaki H; Motoyoshi Y; Takeshita S; Ozawa E; Miuma S; Shibata H; Taura N; Nakao K
    Intervirology; 2010; 53(3):154-60. PubMed ID: 20068349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
    Sakaguchi S; Wing K; Yamaguchi T
    Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway.
    Polanczyk MJ; Hopke C; Vandenbark AA; Offner H
    J Neurosci Res; 2006 Aug; 84(2):370-8. PubMed ID: 16676326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and activation requirements of contact-dependent immune suppression by human regulatory T cells.
    Hagness M; Henjum K; Landskron J; Brudvik KW; Bjørnbeth BA; Foss A; Taskén K; Aandahl EM
    J Immunol; 2012 Jun; 188(11):5459-66. PubMed ID: 22539784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction, control, and plasticity of Treg cells: the immune regulatory network revised?
    Barnaba V; Schinzari V
    Eur J Immunol; 2013 Feb; 43(2):318-22. PubMed ID: 23408318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
    Shen C; Yan WZ; Zhao CY; Che HH; Liu XY; Liu ZZ; Wang YD; Wang W; Li M; Gao J
    J Microbiol Immunol Infect; 2015 Apr; 48(2):137-46. PubMed ID: 24388581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.